Advancements and challenges in amyotrophic lateral sclerosis

Area of Science:

• Neuroscience
• Neurology
• Pharmacology

Background:

• Amyotrophic lateral sclerosis (ALS) presents significant challenges due to its complexity and varied symptoms.
• Current treatments offer limited efficacy, highlighting a critical need for novel therapeutic strategies.

Purpose of the Study:

• To review the underlying mechanisms of ALS, including neuroinflammation, excitotoxicity, mitochondrial dysfunction, and hypermetabolism.
• To explore current research on developing novel drugs targeting these pathways for ALS treatment.

Main Methods:

• Literature review of scientific articles and clinical trial data.
• Analysis of research on molecular mechanisms and therapeutic targets in ALS.

Main Results:

• Identified key pathological pathways in ALS: neuroinflammation, glutamate excitotoxicity, mitochondrial dysfunction, and hypermetabolism.
• Highlighted ongoing efforts to develop targeted therapies for these mechanisms.

Conclusions:

• Despite progress, a significant unmet need for effective ALS treatments persists.
• Emphasized the urgency for continued research and investment in novel ALS therapies.